Tysabri To Return To Market

A Food and Drug Administration advisory committee voted unanimously to allow the recalled multiple sclerosis drug Tysabri back on the market. Shares of Elan Corp. (ELN) jumped $3.11 to close at $15.81 while Biogen Idec Inc. (BIIB) stock leaped $3.50 to close at $49.00.